‘Deep structural problems’: Examining the US failure to quickly develop a coronavirus test

screenshot one map shows how many coronavirus tests each us state has done so far
Credit: Jim Urquhart/Reuters
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

On a Jan. 15 conference call, a leading scientist at the federal Centers for Disease Control and Prevention assured local and state public health officials from across the nation that there would soon be a test to detect a mysterious virus spreading from China. …

Three weeks later … one of the first CDC test kits arrived in a Federal Express package at a public health laboratory on the east side of Manhattan. …

For hours, lab technicians struggled to verify that the test worked. Each time, it fell short, producing untrustworthy results.

In their private communications, scientists at academic, hospital and public health labs — one layer removed from federal agency operations — expressed dismay at the failure to move more quickly and frustration at bureaucratic demands that delayed their attempts to develop alternatives to the CDC test.

Related article:  Infographic: No country is prepared for a pandemic, report says

On March 12, [Anthony] Fauci, who runs the National Institute of Allergy and Infectious Diseases, told lawmakers the problem was not simply the failure of the CDC test. The coronavirus testing debacle had exposed deep structural problems in the nation’s public health system, he said.

“Yeah, it is a failing, let’s admit it,” he said. “The idea of anybody getting it easily the way people in other countries are doing it, we’re not set up for that. Do I think we should be? Yes, but we’re not.”

Read the original post

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend